Ono Pharmaceutical

4528.TPharmaceutical

Key numbers · FY ended 2026-03

Revenue¥515.8bn+5.9% YoY Operating income¥92.2bn+54.4% YoY Net income (owners)¥69.8bn+39.4% YoY Total assets¥1.11T+4.0% YoY EPS (basic)¥148.49+39.4% YoY

Full financial history and reports →

Stock price4528 · View chart ↗

Open the price chart on TradingView.

Latest filings

Wed, Sep 3 · JST1 filing

16:005% STAKEOno Pharmaceutical · BlackRock Japan Co., Ltd. + 12 joint holders · 7.69% → 4.65%−3.04pp

Mon, Aug 4 · JST1 filing

09:00MATERIALOno Pharmaceutical · Change in parent company or specified subsidiary

All filings →

Major holders (5%+) · 0

Holder	Stake	Change	Filed

No holder currently reports 5% or more.

Each holder's own ratio from its most recent large-shareholding report.